Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jill Sisco"'
Autor:
Eliza B. Geer, Jill Sisco, Daphne T. Adelman, William H. Ludlam, Asi Haviv, Shuqian Liu, Susan D. Mathias, Dana Gelbaum, Lizheng Shi
Publikováno v:
BMC Endocrine Disorders, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background Acromegaly patients managed on Somatostatin receptor ligands (SRLs), the most common first-line pharmacotherapy for acromegaly, may still experience acromegaly symptoms such as headache, sweating, fatigue, soft tissue swelling, an
Externí odkaz:
https://doaj.org/article/62aa9e604c8d4aadb861a8c07a576255
Publikováno v:
Future Rare Diseases. 2
What is this summary about? Oral octreotide is the first oral medication (taken by mouth, twice a day) in the class of drugs called somatostatin receptor ligands that is available in the USA for maintaining control of acromegaly. It was approved by t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8ad8d1f86b7b214e8cdfb8b61e2f0d6
https://doi.org/10.2217/frd-2022-0006
https://doi.org/10.2217/frd-2022-0006
Autor:
William H. Ludlam, Maria Fleseriu, Leon Fogelfeld, Susan D. Mathias, Jill Sisco, Ross D. Crosby, Murray B. Gordon, Asi Haviv
Publikováno v:
Pituitary
Purpose The Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ) is a new patient-reported outcome (PRO) measure for patients with acromegaly receiving injectable somatostatin analogs (SSAs) to assess clinical symptoms and adverse drug reaction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d720b08dc8234fd6070c8e9e54ca11b7
http://europepmc.org/articles/PMC7316852
http://europepmc.org/articles/PMC7316852
Autor:
Dana Gelbaum, Shuqian Liu, Daphne T. Adelman, William H. Ludlam, Asi Haviv, Jill Sisco, Susan D. Mathias, Lizheng Shi, Eliza B Geer
Publikováno v:
Pituitary
Background Acromegaly patients, even those with IGF-1 values within the normal range receiving somatostatin receptor ligands (SRLs), often suffer from significant symptoms. It is not known to what extent patients’ medical providers are aware of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2d2109cbf6fa19c7aede005fd008c29
https://doi.org/10.1007/s11102-019-01013-2
https://doi.org/10.1007/s11102-019-01013-2
Autor:
Jill Sisco, Aart Jan van der Lely
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 10, Iss 1363, p 1363 (2021)
Journal of Clinical Medicine, Vol 10, Iss 1363, p 1363 (2021)
Acromegaly is a rare disease and the clinical features of acromegaly develop insidiously; its diagnosis is often significantly delayed. Therefore, earlier diagnosis will improve the quality of life of the patient and reduce the need for other therapi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::033cda36a5ef80c03c90886dd0d2ffee
http://europepmc.org/articles/PMC8036484
http://europepmc.org/articles/PMC8036484
Autor:
Susan D. Mathias, Leon Fogelfeld, William H. Ludlam, Asi Haviv, Jill Sisco, Murray B. Gordon, Hilary H. Colwell, Maria Fleseriu
Publikováno v:
Pituitary
Purpose Somatostatin analogs (SSAs) represent a mainstay of medical treatment for acromegaly, currently available as either intramuscular or deep subcutaneous injections. Patient-reported outcomes (PROs) are increasingly common as relevant outcomes i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeabd0e0bd8acc9e9f9111f601a63a17
https://pubmed.ncbi.nlm.nih.gov/31522359
https://pubmed.ncbi.nlm.nih.gov/31522359
Autor:
Asi Haviv, Lizheng Shi, Shuqian Liu, Susan D. Mathias, Jill Sisco, Dana Gelbaum, Daphne T. Adelman, Eliza B Geer, William H. Ludlam
Publikováno v:
Journal of the Endocrine Society
Aim To understand how endocrinology health care professionals’ (HCP) perceive their acromegaly patients (pts) treatment outcomes Methods We undertook a two-staged study in which US acromegaly pts on a stable dose of SSAs for the past year completed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37fa3ad27251f4daf5fed9900a06b902
https://doi.org/10.1210/js.2019-sun-lb078
https://doi.org/10.1210/js.2019-sun-lb078
Autor:
Eliza B Geer, Lizheng Shi, Dana Gelbaum, Shuqian Liu, Susan D. Mathias, Asi Haviv, Daphne T. Adelman, William H. Ludlam, Jill Sisco
Publikováno v:
Journal of the Endocrine Society
Aim To understand concordance between outcomes reported by US acromegaly patients (pts) treated with long-acting somatostatin analogues (SSA) and those perceived by their treating endocrinology health care professional (HCP). Methods US acromegaly pt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ca54a22e9c178d12a448fd57cec0dff
https://doi.org/10.1210/js.2019-sun-lb077
https://doi.org/10.1210/js.2019-sun-lb077
Autor:
Daphne T. Adelman, Asi Haviv, Eliza B Geer, Dana Gelbaum, Shuqian Liu, Jill Sisco, William H. Ludlam, Susan D. Mathias, Lizheng Shi
Publikováno v:
Journal of the Endocrine Society
Aims This study seeks to understand patient-reported outcomes by describing the disease burden for US acromegaly patients (pts) treated with long-acting somatostatin analogues (SSA). Methods We undertook a two-staged study in which US acromegaly pts
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2c25e3ee82a6f2c42c53e9620f63f31
https://doi.org/10.1210/js.2019-sat-434
https://doi.org/10.1210/js.2019-sat-434
Autor:
Maria Fleseriu, Leon Fogelfeld, Murray Gordon, Jill Sisco None, Hilary Colwell, Asi Haviv, Susan Mathias
Publikováno v:
Endocrine Practice. 22:327
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6584653dba1be7d776a0e6de96aaf130
https://doi.org/10.1016/s1530-891x(20)44872-4
https://doi.org/10.1016/s1530-891x(20)44872-4